Search results
Novartis reports Phase III data for trials of remibrutinib to treat CSU
Clinical Trials Arena via Yahoo Finance· 9 hours agoNovartis has released new data from two Phase III clinical trials confirming the sustained efficacy...
Summit reports data from Phase III NSCLC treatment trial
Clinical Trials Arena via Yahoo Finance· 12 hours agoSummit Therapeutics has revealed that its Phase III HARMONi-2 (AK112-303) clinical trial of...
NHS launches personalised mRNA cancer vaccines trial
Clinical Trials Arena via Yahoo Finance· 9 hours agoThe vaccine being trialled utilises mRNA technology, similar to that of the Pfizer-BioNTech Covid-19 vaccine and is tailored to the individual's cancer...
Gilead’s Phase III urothelial cancer trial fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 12 hours agoGilead Sciences has reported that its Phase III TROPiCS-04 clinical trial of Trodelvy in patients...
NS Pharma Shares Preliminary Results of Viltolarsen (NS-065 / NCNP-01) Phase 3 Clinical Trial...
FOX 59 Indianapolis· 4 days agoNS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd., announced today that it has received preliminary analysis results from the global Phase< ...
Summit Therapeutics' Lung Cancer Therapy Ivonescimab Shows Improved Progression-Free Survival Versus...
Benzinga via Yahoo Finance· 4 hours agoThursday, Summit Therapeutics Inc (NASDAQ:SMMT) announced that Phase 3 HARMONi-2, or AK112-303, met...
Navigate BioPharma Services, Inc. Launch Assay for Precise Measurement of Radioligand Therapy...
Benzinga· 38 minutes agoCARLSBAD, Calif., May 31, 2024 /PRNewswire/ -- Navigate BioPharma Services, Inc., a specialty laboratory offering high-quality, innovative precision medicine solutions and bioanalytics for clinical development and
Untapped opportunities: Fulfilling the promise of decentralized clinical trials
Pharmaceutical Technology via Yahoo Finance· 1 day agoDCTs and hybrid digital trials are on the rise – and are driving new complexities in clinical trial...
ICMR, NIV to start phase-3 clinical trials of recombinant dengue vax: Centre
Investing.com· 3 days agoICMR, NIV to start phase-3 clinical trials of recombinant dengue vax: Centre
Moderna's RSV vaccine for older adults approved
Axios· 4 hours agoWhy it matters: It's Moderna's second approved product, and company officials said it's the first mRNA vaccine approved for a disease other than...
